Colorectal Cancer New Protocol: Tucatinib and Trastuzumab for Metastatic Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Indication: Encorafenib, Binimetinib, and Cetuximab for bRAF V600E Mutant Colorectal Cancer Ulas D. Bayraktar, MD 2023-03-15
Colorectal Cancer New Indication: Pembrolizumab for MSI-High Colorectal Cancer Ulas D. Bayraktar, MD 2022-07-16
